
Photo taken from IARC/LinkedIn
Sep 9, 2024, 14:40
New study suggests significant overdiagnosis of prostate cancer in Europe – IARC
IARC – International Agency for Research on Cancer shared the following on LinkedIn:
“A new study, published today in The BMJ, suggests significant overdiagnosis of prostate cancer in Europe due to highly variable patterns of opportunistic testing with a blood test that measures the amount of prostate-specific antigen (PSA).”
Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso
Source: IARC – International Agency for Research on Cancer/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20